FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4256334189> ?p ?o ?g. }

• W4256334189 abstract "Background Neurocysticercosis is an infection of the brain by the larval stage of the pork tapeworm. In endemic areas it is a common cause of epilepsy. Anthelmintics (albendazole or praziquantel) may be given to kill the parasites. However, there are potential adverse effects, and the parasites may eventually die without treatment. Objectives To assess the effectiveness and safety of anthelmintics for people with neurocysticercosis. Search methods In May 2009 we searched the Cochrane Infectious Diseases Group Specialized Register, CENTRAL (The Cochrane Library 2008, Issue 3), MEDLINE, EMBASE, LILACS, and the mRCT. Selection criteria Randomized controlled trials comparing anthelmintics with placebo, no anthelmintic, or other anthelmintic regimen for people with neurocysticercosis. Data collection and analysis Two authors independently selected trials, extracted data, and assessed each trial's risk of bias. We calculated risk ratios (RR) for dichotomous variables, with 95% confidence intervals (CI). We pooled data from trials with similar interventions and outcomes. Main results For viable lesions in children, there were no trials. For viable lesions in adults, no difference was detected for albendazole compared with no treatment for recurrence of seizures (116 participants, one trial); but fewer participants with albendazole had lesions at follow up (RR 0.56, 95% CI 0.45 to 0.70; 192 participants, two trials). For non‐viable lesions in children, seizures recurrence was less common with albendazole compared with no treatment (RR 0.49, 95% CI 0.32 to 0.75; 329 participants, four trials). There was no difference detected in the persistence of lesions at follow up (570 participants, six trials). For non‐viable lesions in adults, there were no trials. In trials including viable, non‐viable or mixed lesions (in both children and adults), headaches were more common with albendazole alone (RR 9.49, 95% CI 1.40 to 64.45; 106 participants, two trials), but no difference was detected in one trial giving albendazole with corticosteroids (116 participants, one trial). Authors' conclusions In patients with viable lesions, evidence from trials of adults suggests albendazole may reduce the number of lesions. In trials of non‐viable lesions, seizure recurrence was substantially lower with albendazole, which is counter‐intuitive. It may be that steroids influence headache during treatment, but further research is needed to test this." @default.
• W4256334189 created "2022-05-12" @default.
• W4256334189 creator A5006890050 @default.
• W4256334189 creator A5073340614 @default.
• W4256334189 creator A5081067838 @default.
• W4256334189 date "2010-01-20" @default.
• W4256334189 modified "2023-09-26" @default.
• W4256334189 title "Anthelmintics for people with neurocysticercosis" @default.
• W4256334189 cites W1597938189 @default.
• W4256334189 cites W1965406151 @default.
• W4256334189 cites W1975158482 @default.
• W4256334189 cites W1975854621 @default.
• W4256334189 cites W1977764337 @default.
• W4256334189 cites W1990265360 @default.
• W4256334189 cites W1991049989 @default.
• W4256334189 cites W1992886840 @default.
• W4256334189 cites W1996532038 @default.
• W4256334189 cites W2006606582 @default.
• W4256334189 cites W2007998264 @default.
• W4256334189 cites W2010772468 @default.
• W4256334189 cites W2014775443 @default.
• W4256334189 cites W2015302256 @default.
• W4256334189 cites W2021095368 @default.
• W4256334189 cites W2032835790 @default.
• W4256334189 cites W2033890227 @default.
• W4256334189 cites W2049715016 @default.
• W4256334189 cites W2051686752 @default.
• W4256334189 cites W2057635878 @default.
• W4256334189 cites W2060753642 @default.
• W4256334189 cites W2060932211 @default.
• W4256334189 cites W2061489335 @default.
• W4256334189 cites W2064858139 @default.
• W4256334189 cites W2068132217 @default.
• W4256334189 cites W2071509824 @default.
• W4256334189 cites W2075598947 @default.
• W4256334189 cites W2078007087 @default.
• W4256334189 cites W2090951595 @default.
• W4256334189 cites W2093176269 @default.
• W4256334189 cites W2093694825 @default.
• W4256334189 cites W2106246969 @default.
• W4256334189 cites W2125910347 @default.
• W4256334189 cites W2126863663 @default.
• W4256334189 cites W2133658628 @default.
• W4256334189 cites W2150840647 @default.
• W4256334189 cites W2156056941 @default.
• W4256334189 cites W2161047526 @default.
• W4256334189 cites W2315095414 @default.
• W4256334189 cites W3027141276 @default.
• W4256334189 cites W4234995015 @default.
• W4256334189 cites W4246491208 @default.
• W4256334189 doi "https://doi.org/10.1002/14651858.cd000215.pub3" @default.
• W4256334189 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20091504" @default.
• W4256334189 hasPublicationYear "2010" @default.
• W4256334189 type Work @default.
• W4256334189 citedByCount "23" @default.
• W4256334189 countsByYear W42563341892012 @default.
• W4256334189 countsByYear W42563341892013 @default.
• W4256334189 countsByYear W42563341892014 @default.
• W4256334189 countsByYear W42563341892015 @default.
• W4256334189 countsByYear W42563341892016 @default.
• W4256334189 countsByYear W42563341892018 @default.
• W4256334189 countsByYear W42563341892019 @default.
• W4256334189 countsByYear W42563341892020 @default.
• W4256334189 countsByYear W42563341892021 @default.
• W4256334189 countsByYear W42563341892023 @default.
• W4256334189 crossrefType "reference-entry" @default.
• W4256334189 hasAuthorship W4256334189A5006890050 @default.
• W4256334189 hasAuthorship W4256334189A5073340614 @default.
• W4256334189 hasAuthorship W4256334189A5081067838 @default.
• W4256334189 hasBestOaLocation W42563341892 @default.
• W4256334189 hasConcept C126322002 @default.
• W4256334189 hasConcept C141071460 @default.
• W4256334189 hasConcept C142724271 @default.
• W4256334189 hasConcept C165901193 @default.
• W4256334189 hasConcept C168563851 @default.
• W4256334189 hasConcept C187212893 @default.
• W4256334189 hasConcept C197934379 @default.
• W4256334189 hasConcept C203014093 @default.
• W4256334189 hasConcept C204787440 @default.
• W4256334189 hasConcept C27081682 @default.
• W4256334189 hasConcept C2776225656 @default.
• W4256334189 hasConcept C2776478404 @default.
• W4256334189 hasConcept C2776908094 @default.
• W4256334189 hasConcept C2777065887 @default.
• W4256334189 hasConcept C2779744950 @default.
• W4256334189 hasConcept C2780449708 @default.
• W4256334189 hasConcept C2781413609 @default.
• W4256334189 hasConcept C42972112 @default.
• W4256334189 hasConcept C44249647 @default.
• W4256334189 hasConcept C535046627 @default.
• W4256334189 hasConcept C71924100 @default.
• W4256334189 hasConcept C82789193 @default.
• W4256334189 hasConcept C95190672 @default.
• W4256334189 hasConceptScore W4256334189C126322002 @default.
• W4256334189 hasConceptScore W4256334189C141071460 @default.
• W4256334189 hasConceptScore W4256334189C142724271 @default.
• W4256334189 hasConceptScore W4256334189C165901193 @default.
• W4256334189 hasConceptScore W4256334189C168563851 @default.
• W4256334189 hasConceptScore W4256334189C187212893 @default.
• W4256334189 hasConceptScore W4256334189C197934379 @default.

• next